Heilongjiang ZBD Pharmaceutical Secures Approval for Chemical Raw Material Drug Listing

MT NewswiresDec 17, 2024 03:44 ET

ZBD Pharma Gets China Approval for Antibacterial Injection

MT NewswiresDec 3, 2024 02:59 ET

Heilongjiang ZBD Pharmaceutical Co., Ltd.'s (SHSE:603567) Stock Price Dropped 3.8% Last Week; Private Equity Firms Would Not Be Happy

Simply Wall StNov 18, 2024 22:22 ET

Report for the third quarter of 2024 of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

SZSIOct 29, 2024 12:00 ET · Announcements

While Shareholders of Heilongjiang ZBD Pharmaceutical (SHSE:603567) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Simply Wall StOct 25, 2024 00:39 ET

We Think Heilongjiang ZBD Pharmaceutical (SHSE:603567) Can Stay On Top Of Its Debt

Simply Wall StOct 3, 2024 23:52 ET

China Rejects ZBD Pharmaceutical's Application For Skin Infection Drug

MT NewswiresAug 27, 2024 01:56 ET

Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

SZSIAug 26, 2024 12:00 ET · Announcements

Summary of the 2024 semi-annual report of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

SZSIAug 26, 2024 12:00 ET · Announcements

Improved Earnings Required Before Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) Shares Find Their Feet

Simply Wall StAug 20, 2024 23:34 ET

Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Annual Report 2023 - Revised Edition Summary.

SZSIAug 7, 2024 12:00 ET · Announcements

Heilongjiang ZBD Pharmaceutical Co., Ltd. 2023 Semi-Annual Report - Revised Edition Summary.

SZSIAug 7, 2024 12:00 ET · Announcements

Heilongjiang ZBD Pharmaceutical Co., Ltd. Q1/2024 Revised Report

SZSIAug 7, 2024 12:00 ET · Announcements

Heilongjiang ZBD Pharmaceutical Co., Ltd. Annual Report 2023 - Revised Edition.

SZSIAug 7, 2024 12:00 ET · Announcements

Heilongjiang ZBD Pharmaceutical Co., Ltd. 2023 Interim Report - Revised Version.

SZSIAug 7, 2024 12:00 ET · Announcements

Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Q3 2023 Revised Report

SZSIAug 7, 2024 12:00 ET · Announcements

Heilongjiang ZBD Pharmaceutical Co., Ltd. Q1 2023 Revised Report

SZSIAug 7, 2024 12:00 ET · Announcements

Private Equity Firms Are Heilongjiang ZBD Pharmaceutical Co., Ltd.'s (SHSE:603567) Biggest Owners and Were Hit After Market Cap Dropped CN¥517m

Simply Wall StJul 29, 2024 18:18 ET

ZBD Pharmaceutical Gets Nod to Market Bromhexine Hydrochloride Injection

MT NewswiresJul 19, 2024 02:19 ET

ZBD Pharmaceutical Gets Nod to Trial Qingjianghewei Granules

MT NewswiresJul 11, 2024 05:19 ET